Splenomegaly at the end of the experimental period (week 5)—a hallmark of the cGvHD-induced autoimmunity model—was lower in CD6−/− mice and explained by lower in vivo proliferation (low BrdU incorporation in the absence of vis-à-vis differences in apoptotic cell levels). The gene discussed is CD6; the disease is Autoimmunity.